Results 211 to 220 of about 47,659 (253)

The role of phosphodiesterase inhibitors in impotence

Expert Opinion on Investigational Drugs, 1997
Penile erection is mediated by nitric oxide (NO) and its second messenger cyclic guanosine monophosphate (cGMP). The activity of cGMP is modulated by the enzyme phosphodiesterase (PDE). The most important physiological isoform of the enzyme in the penis is PDE5.
openaire   +2 more sources

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives

Pharmaceuticals, 2023
Ahmed Elhady, Ashraf Abadi, Mohammad Abdel-Halim   +2 more
exaly  

Phosphodiesterase Inhibitors

2012
GOMEZ BATEMAN SYLVIE, JURKIEWICZ ILONA, HERMANN GESINE JOHANNA, MATTHEWS IAN TIMOTHY WILLIAM, KIRBY JONATHAN PETER, LOPEZ ELENA HERNANDEZ, KULKARNI MANISHA SAMAR, EDWARDS PETER, KING WILLIAM RICHARD, THOMAS HOWARD CHRISTOPHER, THURSZ MARK RICHARD, LERMA ISRAEL CONESA   +11 more
  +6 more sources

Phosphodiesterase inhibitors

Baillière's Clinical Anaesthesiology, 1994
J. Boldt, G. Hempelmann
openaire   +1 more source

The phosphodiesterase inhibitor ‘war’

BJU International, 2003
openaire   +2 more sources

Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis

European Urology Focus, 2017
Marrissa Martyn-St James, Eva Kaltenthaler, Katy Cooper   +2 more
exaly  

PHOSPHODIESTERASE 4 INHIBITORS

2004
HOPPER ALLEN T, LIU RUIPING
openaire   +7 more sources

EVIDENCE FOR CONTAMINATION OF HERBAL ERECTILE DYSFUNCTION PRODUCTS WITH PHOSPHODIESTERASE TYPE 5 INHIBITORS

Journal of Urology, 2005
Karen Hersey, Neil Fleshner, Hans Adomat   +2 more
exaly  

Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy

Journal of Urology, 2015
Derya Tilki, Lars Budaeus, Pierre Tennstedt   +2 more
exaly  

Phosphodiesterase inhibitors

2018
openaire   +1 more source